apex pharm ltd

Live EstablishedSmallHealthy

apex pharm ltd Company Information

Share APEX PHARM LTD

Company Number

08304463

Shareholders

tahir mahmood

amir waheed ikhlas

View All

Group Structure

View All

Industry

Other human health activities

 

Registered Address

suite 1, 177 lees road, oldham, OL4 1JP

apex pharm ltd Estimated Valuation

£1.8m

Pomanda estimates the enterprise value of APEX PHARM LTD at £1.8m based on a Turnover of £4.1m and 0.43x industry multiple (adjusted for size and gross margin).

apex pharm ltd Estimated Valuation

£348.8k

Pomanda estimates the enterprise value of APEX PHARM LTD at £348.8k based on an EBITDA of £104.7k and a 3.33x industry multiple (adjusted for size and gross margin).

apex pharm ltd Estimated Valuation

£633.3k

Pomanda estimates the enterprise value of APEX PHARM LTD at £633.3k based on Net Assets of £269.6k and 2.35x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Apex Pharm Ltd Overview

Apex Pharm Ltd is a live company located in oldham, OL4 1JP with a Companies House number of 08304463. It operates in the other human health activities sector, SIC Code 86900. Founded in November 2012, it's largest shareholder is tahir mahmood with a 33.3% stake. Apex Pharm Ltd is a established, small sized company, Pomanda has estimated its turnover at £4.1m with healthy growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Apex Pharm Ltd Health Check

Pomanda's financial health check has awarded Apex Pharm Ltd a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3.5out of 5
positive_score

5 Strong

positive_score

1 Regular

positive_score

4 Weak

size

Size

annual sales of £4.1m, make it larger than the average company (£797.3k)

£4.1m - Apex Pharm Ltd

£797.3k - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 13%, show it is growing at a faster rate (6.5%)

13% - Apex Pharm Ltd

6.5% - Industry AVG

production

Production

with a gross margin of 21%, this company has a higher cost of product (36.4%)

21% - Apex Pharm Ltd

36.4% - Industry AVG

profitability

Profitability

an operating margin of 2.6% make it less profitable than the average company (5.5%)

2.6% - Apex Pharm Ltd

5.5% - Industry AVG

employees

Employees

with 27 employees, this is above the industry average (19)

27 - Apex Pharm Ltd

19 - Industry AVG

paystructure

Pay Structure

on an average salary of £27k, the company has an equivalent pay structure (£27k)

£27k - Apex Pharm Ltd

£27k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £152.2k, this is more efficient (£51.3k)

£152.2k - Apex Pharm Ltd

£51.3k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 96 days, this is later than average (22 days)

96 days - Apex Pharm Ltd

22 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 138 days, this is slower than average (17 days)

138 days - Apex Pharm Ltd

17 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Apex Pharm Ltd

- - Industry AVG

cashbalance

Cash Balance

There is insufficient data available for this Key Performance Indicator!

- - Apex Pharm Ltd

- - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 82.3%, this is a higher level of debt than the average (27.8%)

82.3% - Apex Pharm Ltd

27.8% - Industry AVG

APEX PHARM LTD financials

EXPORTms excel logo

Apex Pharm Ltd's latest turnover from December 2023 is estimated at £4.1 million and the company has net assets of £269.6 thousand. According to their latest financial statements, Apex Pharm Ltd has 27 employees and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013
Turnover4,108,3813,269,2753,406,1792,847,3422,068,642898,4452,692,3382,576,9011,152,397401,728475,382
Other Income Or Grants
Cost Of Sales3,244,0492,606,7132,762,7332,303,3041,651,714725,9222,118,7602,012,840927,188325,921386,673
Gross Profit864,332662,563643,446544,039416,928172,523573,578564,062225,20975,80788,709
Admin Expenses759,605630,291630,758550,999387,493153,169525,800530,948176,91762,03381,473
Operating Profit104,72732,27212,688-6,96029,43519,35447,77833,11448,29213,7747,236
Interest Payable
Interest Receivable3681,148577164
Pre-Tax Profit104,72732,27212,688-6,96029,43519,35447,77833,48349,44014,3517,400
Tax-26,182-6,132-2,411-5,593-3,677-9,078-6,696-9,888-3,014-1,702
Profit After Tax78,54526,14010,277-6,96023,84215,67738,70026,78639,55211,3375,698
Dividends Paid
Retained Profit78,54526,14010,277-6,96023,84215,67738,70026,78639,55211,3375,698
Employee Costs727,707638,273244,048236,250233,194272,675704,000637,381293,409129,297148,833
Number Of Employees27251010101232301467
EBITDA*104,72732,27212,688-6,96029,43519,35447,77833,11450,82415,7368,988

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013
Tangible Assets441,648364,184373,143385,098368,693319,93917,0198,66510,12810,9158,792
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets441,648364,184373,143385,098368,693319,93917,0198,66510,12810,9158,792
Stock & work in progress43,00041,86033,260
Trade Debtors1,084,337883,270947,164729,226500,478160,411435,549408,778647
Group Debtors
Misc Debtors
Cash294,504164,83965,764
misc current assets
total current assets1,084,337883,270947,164729,226500,478160,411435,549408,778337,504207,34699,024
total assets1,525,9851,247,4541,320,3071,114,324869,171480,350452,568417,443347,632218,261107,816
Bank overdraft
Bank loan
Trade Creditors 1,233,1611,022,4141,110,983909,692707,579342,600330,495334,070290,945201,126102,018
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
total current liabilities1,233,1611,022,4141,110,983909,692707,579342,600330,495334,070290,945201,126102,018
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities23,23033,99144,41550,000
provisions
total long term liabilities23,23033,99144,41550,000
total liabilities1,256,3911,056,4051,155,398959,692707,579342,600330,495334,070290,945201,126102,018
net assets269,594191,049164,909154,632161,592137,750122,07383,37356,68717,1355,798
total shareholders funds269,594191,049164,909154,632161,592137,750122,07383,37356,68717,1355,798
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013
Operating Activities
Operating Profit104,72732,27212,688-6,96029,43519,35447,77833,11448,29213,7747,236
Depreciation2,5321,9621,752
Amortisation
Tax-26,182-6,132-2,411-5,593-3,677-9,078-6,696-9,888-3,014-1,702
Stock-43,0001,1408,60033,260
Debtors201,067-63,894217,938228,748340,067-275,13826,771408,778-647647
Creditors210,747-88,569201,291202,113364,97912,105-3,57543,12589,81999,108102,018
Accruals and Deferred Income
Deferred Taxes & Provisions
Cash flow from operations88,2251,465-6,370-33,59548,754302,9208,354-296,235130,262102,58376,044
Investing Activities
capital expenditure-77,4648,95911,955-16,405-48,754-302,920-8,3541,463-1,745-4,085-10,544
Change in Investments
cash flow from investments-77,4648,95911,955-16,405-48,754-302,920-8,3541,463-1,745-4,085-10,544
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities-10,761-10,424-5,58550,000
share issue-100100
interest3681,148577164
cash flow from financing-10,761-10,424-5,58550,0002681,148577264
cash and cash equivalents
cash-294,504129,66599,07565,764
overdraft
change in cash-294,504129,66599,07565,764

apex pharm ltd Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for apex pharm ltd. Get real-time insights into apex pharm ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Apex Pharm Ltd Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for apex pharm ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in OL4 area or any other competitors across 12 key performance metrics.

apex pharm ltd Ownership

APEX PHARM LTD group structure

Apex Pharm Ltd has no subsidiary companies.

Ultimate parent company

APEX PHARM LTD

08304463

APEX PHARM LTD Shareholders

tahir mahmood 33.33%
amir waheed ikhlas 33.33%
mohammed khuram shahzad 33.33%

apex pharm ltd directors

Apex Pharm Ltd currently has 3 directors. The longest serving directors include Mr Amir Ikhlas (Nov 2012) and Mr Mohammed Shahzad (Nov 2012).

officercountryagestartendrole
Mr Amir IkhlasUnited Kingdom39 years Nov 2012- Director
Mr Mohammed ShahzadEngland42 years Nov 2012- Director
Mr Tahir MahmoodEngland44 years Jan 2018- Director

P&L

December 2023

turnover

4.1m

+26%

operating profit

104.7k

0%

gross margin

21.1%

+3.81%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

269.6k

+0.41%

total assets

1.5m

+0.22%

cash

0

0%

net assets

Total assets minus all liabilities

apex pharm ltd company details

company number

08304463

Type

Private limited with Share Capital

industry

86900 - Other human health activities

incorporation date

November 2012

age

13

incorporated

UK

ultimate parent company

None

accounts

Micro-Entity Accounts

last accounts submitted

December 2023

previous names

N/A

accountant

-

auditor

-

address

suite 1, 177 lees road, oldham, OL4 1JP

Bank

-

Legal Advisor

-

apex pharm ltd Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to apex pharm ltd.

apex pharm ltd Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for APEX PHARM LTD. This can take several minutes, an email will notify you when this has completed.

apex pharm ltd Companies House Filings - See Documents

datedescriptionview/download